Repeated cycles of peptide receptor radionuclide therapy (PRRT) - Side-effects and response to the radioisotope 90Y-DOTA-TATE or 90Y/177Lu DOTA-TATE therapy in patients with disseminated NET

被引：0
|
作者：
Sowa-Staszczak, Anna [1 ]
Kunikowska, Jolanta [2 ]
Krolicki, Leszek [2 ]
Mikolajczak, Renata [3 ]
Pawlak, Dariusz [3 ]
Stefanska, Agnieszka [1 ]
Tomaszuk, Monika [1 ]
Trofimiuk, Malgorzata [1 ]
Pach, Dorota [1 ]
Hubalewska-Dydejczyk, Alicja [1 ]
机构：
[1] Jagiellonian Univ, Coll Med, Dept Endocrinol, Nucl Med Unit, Krakow, Poland
[2] Warsaw Med Univ, Dept Nucl Med, Warsaw, Poland
[3] IAE Radioisotope Ctr POLATOM, Res & Dev, Otwock, Poland
来源：
JOURNAL OF NUCLEAR MEDICINE | 2011年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
300
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-TATE in Patients with Advanced GEP NENS: Present and Future Directions
    del Olmo-Garcia, Maria I.
    Prado-Wohlwend, Stefan
    Bello, Pilar
    Segura, Angel
    Merino-Torres, Juan F.
    CANCERS, 2022, 14 (03)
  • [42] Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [177Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumours
    Geenen, Lorain
    Nonnekens, Julie
    Konijnenberg, Mark
    Baatout, Sarah
    De Jong, Marion
    Aerts, An
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 102 : 1 - 11
  • [43] Dosimetry in peptide receptor radionuclide therapy (PRRNT): comparative results using Lu-177 DOTA-TATE, DOTA-NOC und DOTA-TOC
    Schuchardt, C.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S244 - S244
  • [44] Quantitative Imaging of 177Lu in the Presence of 90Y for Peptide Receptor Radionuclide Therapy: A Simulation Study
    Miller, C.
    Rahmim, A.
    Uribe-munoz, C.
    Celler, A.
    MEDICAL PHYSICS, 2020, 47 (06) : E550 - E550
  • [45] Morphologic and metabolic response assessment of 177Lu-DOTA-TATE peptide receptor radionuclide therapy (PRRT) with 68Ga-DOTA-TOC PET/CT
    Gaertner, F. C.
    Hillerer, C.
    Lapa, C.
    Miederer, M.
    D'Alessandria, C.
    Wester, H.
    Schwaiger, M.
    Scheidhauer, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S267 - S267
  • [46] Clinical peptide receptor radionuclide therapy: Kit preparation of 90Y, 177Lu, and 111In DOTATATE
    Ballinger, J. R.
    Tan, Y.
    Allen, S. J.
    Lewington, V. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S425 - S425
  • [47] Serial Tc-99m MAG3/TER measurements for the evaluation of renal function after Y-90 DOTA-TATE peptide receptor radionuclide therapy (PRRT)
    Baum, R. P.
    Prasad, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S377 - S377
  • [48] Long-term side effects in patients with disseminated neuroendocrine tumors who underwent tandem peptide receptor radionuclide therapy (PRRT) with 90Y/177Lu-DOTATATE
    Kunikowska, J.
    Matyskiel, R.
    Pawlak, D.
    Krolicki, L.
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56
  • [49] Incidence of raised HbA1c and correlation with Somatostatin analogue therapy (SSA) in patients with Neuroendocrine Tumours (NET) receiving peptide receptor [177Lu]Lu-DOTA-TATE radionuclide therapy (PRRT)
    Eftychiou, N.
    Ilyas, H.
    Ahmed, H.
    Hassan, F.
    Eccles, A.
    Lewington, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S469 - S470
  • [50] Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma
    Minczeles, Noemie S.
    Bos, Eelke M. M.
    de Leeuw, Reinoud C. C.
    Kros, Johan M. M.
    Konijnenberg, Mark W. W.
    Bromberg, Jacoline E. C.
    de Herder, Wouter W. W.
    Dirven, Clemens M. F.
    Hofland, Johannes
    Brabander, Tessa
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (04) : 1195 - 1204
12345